---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-054457"
form_type: "8-K"
ticker: null
cik: "0001779020"
company_name: "Danimer Scientific, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T19:31:13.877612+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Danimer Q1 revenue $10.2M, loss continues; FY2024 EBITDA guidance at lower end of $(22)-$(32)M

## Summary
- Revenue $10.2M vs $11.9M YoY; PHA revenue up 64% ($3.2M), PLA down $4.3M from Ukraine conflict.
- Adjusted EBITDA $(8.7)M vs $(8.9)M YoY; full-year guidance now 'closer to lower end' of $(22)-$(32)M.
- Starbucks reapportioning Nodax straw business creates near-term Q2/Q3 headwinds; Danimer retains 100%.
- First commercial order received for 20-million-pound cutlery award; $20M ABL facility closed April 19.
- Proposed warrant dividend (1 per 3 shares) contingent on shareholder vote at July 9 annual meeting.

## SEC filing metadata
- accession: 0000950170-24-054457
- form_type: 8-K
- cik: 0001779020
- company_name: Danimer Scientific, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779020/000095017024054457/0000950170-24-054457-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779020/000095017024054457/dnmr-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-054457
- JSON: https://secwatch.observer/filing/0000950170-24-054457.json
- Plain text: https://secwatch.observer/filing/0000950170-24-054457.txt

## Key facts
- Earnings Releases
  Danimer Scientific, Inc. reported first quarter ended March 31, 2024 results: revenue $10.2 million. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: $10.2 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: new avenue to improve our balance sheet leverage, strengthen our capital structure and maximize stockholder value.” First Quarter 2024 Financial Highlights: • Revenues were $10.2 million in the first quarter of 2024 compared to revenue of $11.9 million in the first quarter of 2023. While PHA revenue increased by $3.2 million in the quarter as compared with the
  evidence_url: https://www.sec.gov/Archives/edgar/data/1779020/000095017024054457/0000950170-24-054457-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.